#Ep 5: The Consistent Compounders Show :Stay tuned to catch Saurabh Mukherjea in conversation with Sohini Andani, Fund Manager, SBI Mutual Fund.
you are here: HomeNewsIndia

Govt allows export of COVID-19 PPE medical coveralls; monthly quota fixed at 50 lakh units

The product was banned for export earlier, but it has now been moved to the restricted category.

June 29, 2020 / 06:50 PM IST

Representative image

Partially relaxing export norms, the government on Monday permitted shipments of Personal Protection Equipment (PPE) medical coveralls for COVID-19 with a monthly export quota of 50 lakh units.

The product was banned for export earlier, but it has now been moved to the restricted category.

In a notification, the Directorate General of Foreign Trade (DGFT) said: "A monthly quota of 50 lakh PPE medical coverall for COVID-19 units has been fixed for issuance of export licence to the eligible applicants to export PPE medical coveralls for COVID-19 as per the criteria to be separately issued in a trade notice".

All other items that are part of PPE kits continue to remain prohibited, it said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Commerce and Industry Minister Piyush Goyal tweeted: “Boosting Make in India exports, PPE medical coveralls for COVID-19 have been allowed with a monthly export quota of 50 lakh.”
PTI
first published: Jun 29, 2020 01:37 pm

stay updated

Get Daily News on your Browser
Sections